Exercise and glucagon-like peptide 1 receptor agonists in cardiovascular disease beyond weight loss - Nature

Exercise and glucagon-like peptide 1 receptor agonists in cardiovascular disease beyond weight loss  NatureEffects of exercise and liraglutide on vascular health and inflammation during weight loss maintenance: a prespecified secondary analysis of the S-LiTE trial  NatureWomen’s Health Wednesday: GLP-1 medication and heart health benefits  NEWS10 ABCExercise, not liraglutide alone, drives vascular gains after obesity-related weight loss  News-MedicalA ‘perfect storm’ for bone loss in women: Menopause and GLP-1 weight-loss drugs  UCHealth